ParkCity Medical Centre has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI accredited establishment of the year 2012 is situated in Kuala Lumpur, Malaysia, and contains 300 beds.

CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.